GamaMabs Pharma's Series B Round

GamaMabs Pharma raised a round of funding on December 16, 2015.

GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.…

Articles about GamaMabs Pharma's Series B Round: